M2e peptide vaccine (National Institutes of Health)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameM2e peptide vaccine (National Institutes of Health)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionMatrix protein 2 modulators

TargetsMatrix protein 2

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institutes Of Health

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institutes Of Health

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A